MarketPeel
Pricing
…
EVP, Chief Financial Officer
Edward J. III Dulac
Mon, Jul 22, 2024
Jul 22
received an award in NTLA
96,219 shares @ $0.00
New position
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+7.81%
1M+19.66%
3M—
6M—
1Y—

Recent insider activity at NTLA

Jul 22Edward J. III DulacSold$91.25kJul 2Edward J. III DulacSold$84.19kJul 1Michael P. DubeSold$44.32kMar 2James BastaSold$16.69kMar 2Eliana ClarkSold$8.36kJan 5James BastaSold$95.76kJan 5Michael P. DubeSold$27.53kJan 5Fred E. CohenBought$1.40m
Full NTLA profile →Edward J. III Dulac’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback